Tulisokibart in patients with moderately to severely active Crohn’s disease: efficacy and safety through week 146 from the phase 2 APOLLO-CD study

J Brüning, A DuVall, G Y Melmed, J Kierkus, R Leong, W Zhou, J Song, J Liu, J Shao, A Lim, C A Siegel · Zeitschrift für Gastroenterologie · 2026 · Heft 08 · S. e328-e329